Tubulin polymerization-IN-2 is a potent anticancer agent targeting to β-tubulin with an IC 50 value of 0.92 μM. Tubulin polymerization-IN-2 shows promising activity against various leukemia, non-small lung, renal, prostate, and breast cancer cell lines.